FREEDOM weighs CABG, PCI in patients with diabetes, heart disease

Bypass surgery carries lower risks of death and MI than percutaneous coronary intervention but higher risk of stroke in patients with diabetes who have multivessel disease, according to results of the FREEDOM trial presented at the American Heart Association meeting. "If you were to look solely at death and MI, CABG is clearly superior in this trial," said Dr. Ajay J. Kirtane of the findings. "But the two procedures are clearly different from a patient-oriented perspective, particularly with regards to the invasive nature of the two procedures and the increased stroke risk, especially within 30 days."

View Full Article in:

CardiovascularBusiness.com · TheHeart.org (Montreal) · Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX